genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Authors Posts by Kevin Davies, PhD

Kevin Davies, PhD

Sickle Cell Anemia
Genome Editing

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies

Human DNA editing
Genome Editing

A Story of Perseverance: An Interview with Matthew Porteus

ASGCT 2024 Banners
Genome Editing

ASGCT 2024: David Liu Touts Rapid Evolution of Gene-Sized Programmable Editing Technologies

image of screens in a lecture hall showing the ASGCT logo
Genome Editing

ASGCT 2024: A Video Update from Baltimore

Lucas Harrington
Genome Editing

ASGCT 2024: Mammoth Sizes Up Genome Editing Opportunities

Gene therapy concept. Medical technology. Medtech.
Genome Editing

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop

DNA, genetic elements and icons collection
Touching Base

DNA Day: Deep Dive

MaxCyte ExPERT Platform
Genome Editing

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough

Victoria Gray and her doctor in the hospital where she received CRISPR-therapy for sickle cell disease
Genome Editing

Sickle Cell Salvation: The Victoria Gray Interview

A view of the exhibition floor at SLAS 2024
Artificial Intelligence

Scenes from SLAS: AI, Organs-on-Chips Resonate at Record Lab Automation Show

1 2 3 … 7 > Page 1 of 7

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up